Roivant Sciences Ltd.

NASDAQ (USD): Roivant Sciences Ltd. (ROIV)

Last Price

10.80

Today's Change

+0.06 (0.55%)

Day's Change

10.76 - 11.07

Trading Volume

3,488,884

Overview

Market Cap

7 Billion

Shares Outstanding

738 Million

Avg Volume

4,912,511

Avg Price (50 Days)

10.90

Avg Price (200 Days)

10.54

PE Ratio

2.07

EPS

5.23

Earnings Announcement

12-Aug-2024

Previous Close

10.74

Open

10.77

Day's Range

10.76 - 11.07

Year Range

8.245 - 13.24

Trading Volume

3,488,884

Price Change Highlight

1 Day Change

0.56%

5 Day Change

-2.53%

1 Month Change

2.18%

3 Month Change

-2.09%

6 Month Change

4.15%

Ytd Change

-4.85%

1 Year Change

-1.19%

3 Year Change

8.98%

5 Year Change

3.85%

10 Year Change

3.85%

Max Change

3.85%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment